Leukopak, producto fresco de leucaféresis humana obtenido de sangre periférica normal, 1 bolsa

Leukopaks are highly-enriched leukapheresis-derived products obtained from an IRB-approved collection facility. Leukopaks contain higher concentrations of mononuclear cells, B cells, T cells, stem/progenitor cells, dendritic cells, and other cell types as compared to standard venipuncture collection methods or buffy coat products.

Leukapheresis is performed using the Spectra Optia® Apheresis System with healthy, consented donors following IRB-approved protocols. MNC rich cells are continuously collected from 2-2.5 donor blood volumes into a sterile bag using ACD-A as an anticoagulant. Approximately 120mL of autologous plasma is automatically collected directly into the cell pool following leukapheresis.

After a sample is withdrawn for quality testing, a nominal volume of 290mL is transferred into a sterile transfer bag prior to shipping. The total nucleated cell count is determined using AO/PI from the collection and provided as information. Average full procedures produce ~17.5B TNCs with >90% of collections having 12.5B TNCs or more at release.

These products are released based on the volume of apheresed material provided. Apheresed total nucleated cell (TNC) products typically contain up to 50% T cells, 20% monocytes, 10% B cells, and 10% NK cells, 3% granulocytes, and 3% hematocrit. Cell subtype %s, actual TNC concentrations and cell total counts will vary from collection to collection. Manufactured by AllCells® Additional shipping charges apply for fresh, human origin products.